Catalytic undirected methylation of unactivated C(sp<sup>3</sup>)-H bonds suitable for complex molecules.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39333063.
- Also identified by DOI 10.1038/s41467-024-52245-1 and PMC identifier 11437150.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In pharmaceutical discovery, the "magic methyl" effect describes a substantial improvement in the pharmacological properties of a drug candidate with the incorporation of methyl groups. Therefore, to expedite the synthesis of methylated drug analogs, late-stage, undirected methylations of C(sp<sup>3</sup>)-H bonds in complex molecules would be valuable. However, current methods for site-selective methylations are limited to activated C(sp<sup>3</sup>)-H bonds. Here we describe a site-selective, undirected methylation of unactivated C(sp<sup>3</sup>)-H bonds, enabled by photochemically activated peroxides and a nickel(II) complex whose turnover is enhanced by an ancillary ligand. The methodology displays compatibility with a wide range of functional groups and a high selectivity for tertiary C-H bonds, making it suitable for the late-stage methylation of complex organic compounds that contain multiple alkyl C-H bonds, such as terpene natural products, peptides, and active pharmaceutical ingredients. Overall, this method provides a synthetic tool to explore the "magic methyl" effect in drug discovery.
Medical subject headings
- Nickel